# Operational Research for Cryptococcal Antigen Screening

> **NCT01535469** · PHASE4 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 3049 (actual)

## Conditions studied

- Cryptococcal Meningitis
- Cryptococcus Neoformans
- Cryptococcosis

## Interventions

- **DRUG:** Fluconazole

## Key facts

- **NCT ID:** NCT01535469
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-01
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 3049 (ACTUAL)
- **Last updated:** 2020-06-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01535469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01535469, "Operational Research for Cryptococcal Antigen Screening". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01535469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*